Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.
Transgenic mouse models and other screens are being used to identify potential therapeutic agents for use in clinical trials in Huntington's disease (HD). The development of surrogate markers that can be used in clinical therapeutics is an active area of research. Because HD is relatively uncommon and only a portion of available subjects meet inclusion and exclusion criteria, therapeutic trials are limited by the availability of potential subjects as well as the relative insensitivity of the clinical measures used. Neuroimaging methods offer the potential to provide noninvasive, reproducible, and objective methods not only to better understand the disease process but also to follow in clinical studies to determine if a drug is effective in slowing down disease progression or perhaps even in delaying onset. Following is a review of the literature, which highlights the studies that have been published to date.
Rosas
H D
HD
Center for Neuroimaging of Aging and Neurodegenerative Diseases, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. rosas@helix.mgh.harvard.edu
Feigin
A S
AS
Hersch
Steven M
SM
D015415:Biomarkers; D006801:Humans; D006816:Huntington Disease / Q000000981:diagnostic imaging* / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D049268:Positron-Emission Tomography
D015415:Biomarkers
N Engl J Med. 1987 Feb 12;316(7):357-62
2949152
Brain. 2003 May;126(Pt 5):1127-35
12690052
Mov Disord. 2000 May;15(3):552-60
10830423
Brain. 1990 Oct;113 ( Pt 5):1405-23
2147116
Nat Genet. 1998 Oct;20(2):198-202
9771716
Brain Res. 2000 Jul 14;871(1):127-45
10882792
Brain. 1998 Jul;121 ( Pt 7):1343-55
9679785
Ann Neurol. 1997 Oct;42(4):604-12
9382472
Neurology. 1987 Sep;37(9):1441-7
2957611
Scand J Psychol. 2001 Jul;42(3):287-96
11501742
N Engl J Med. 1994 May 19;330(20):1401-6
8159192
Brain. 2002 Aug;125(Pt 8):1815-28
12135972
Arch Neurol. 1987 Mar;44(3):254-7
2950844
Ann Neurol. 1982 Nov;12(5):425-34
6217782
Nat Med. 2000 Jul;6(7):797-801
10888929
Nat Genet. 1995 May;10(1):104-10
7647777
Ann Neurol. 2000 May;47(5):644-8
10805336
Brain. 1996 Oct;119 ( Pt 5):1633-45
8931586
Neuroreport. 2002 Apr 16;13(5):703-6
11973474
Ann Neurol. 1986 Sep;20(3):296-303
2945510
Ann Neurol. 1998 Feb;43(2):253-5
9485067
Science. 2001 Jul 20;293(5529):493-8
11408619
Curr Opin Neurol. 2003 Aug;16(4):501-6
12869810
Neurobiol Dis. 2001 Jun;8(3):479-91
11447996
Brain. 2000 Jul;123 ( Pt 7):1349-64
10869048
Ann Neurol. 2000 Jul;48(1):72-6
10894218
J Neurosci. 2002 Oct 15;22(20):8942-50
12388601
J Neurosci. 1999 Apr 1;19(7):2522-34
10087066
Ann Neurol. 1997 Feb;41(2):160-5
9029064
Brain Pathol. 1997 Jul;7(3):979-1002
9217979
Cell. 1997 Aug 8;90(3):537-48
9267033
J Med Genet. 1994 Nov;31(11):872-4
7853373
Mov Disord. 1996 Mar;11(2):136-42
8684382
J Neuropsychiatry Clin Neurosci. 2003 Winter;15(1):7-16
12556566
Am J Hum Genet. 1998 May;62(5):1243-7
9545416
Neuron. 1995 May;14(5):1065-74
7748554
Ann Neurol. 2001 Jul;50(1):112-7
11456300
Brain. 1997 Dec;120 ( Pt 12):2207-17
9448576
Neurology. 1999 Sep 11;53(4):806-12
10489045
Neurology. 1998 May;50(5):1357-65
9595987
Neurology. 2002 Mar 12;58(5):695-701
11889230
J Neurosci. 2002 Mar 1;22(5):1592-9
11880489
Brain. 1999 Dec;122 ( Pt 12):2353-63
10581228
Am J Hum Genet. 1997 May;60(5):1202-10
9150168
Neurology. 2001 Aug 28;57(4):658-62
11524475
J Med Genet. 1993 Dec;30(12):987-90
8133509
Neurology. 1986 Jul;36(7):888-94
2940474
Neurology. 2003 May 27;60(10):1615-20
12771251
Brain. 1995 Jun;118 ( Pt 3):689-96
7600086
Nat Genet. 1993 Aug;4(4):387-92
8401587
Ann Neurol. 1996 Jul;40(1):49-54
8687191
J Comput Assist Tomogr. 1992 Sep-Oct;16(5):789-94
1387888
J Neurosci. 2000 Jun 15;20(12):4389-97
10844007
Mov Disord. 1995 Mar;10(2):211-4
7753064
J Neurosci. 2003 Oct 15;23(28):9418-27
14561870
Cell. 1993 Mar 26;72(6):971-83
8458085
J Int Neuropsychol Soc. 2002 Nov;8(7):918-24
12405543
Neuroimage. 2001 Dec;14(6):1238-43
11707080
J Neuropathol Exp Neurol. 1998 May;57(5):369-84
9596408
Brain. 1996 Dec;119 ( Pt 6):2085-95
9010012
J Clin Exp Neuropsychol. 1995 Dec;17(6):868-77
8847393
J Neurosci Methods. 1987 Apr;19(4):305-15
2884352
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1169-77
8229028
Neuron. 2002 Jan 31;33(3):341-55
11832223
Mol Med. 1995 May;1(4):374-83
8521295
Neuroreport. 2001 Oct 29;12(15):3371-3
11711888
Neurology. 1998 Apr;50(4):1033-40
9566391
Annu Rev Neurosci. 1986;9:357-81
3085570
Neurology. 1997 Feb;48(2):394-9
9040728
Brain. 2003 Mar;126(Pt 3):713-23
12566291
Ann Neurol. 1992 Oct;32(4):526-34
1280937
Neurology. 2001 Sep 25;57(6):1025-8
11571328